{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T17:07:26Z","timestamp":1772644046686,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,4]]},"DOI":"10.7759\/cureus.104653","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:04:33Z","timestamp":1772629473000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Multifocal Urothelial Carcinoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Pedro","family":"Serrano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Barros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Dores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An\u00edbal","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel RL","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021, 71:7-33. 10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat M","year":"2021","unstructured":"Roupr\u00eat M, Babjuk M, Burger M, et al.. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol. 2021, 79:62-79. 10.1016\/j.eururo.2020.05.042","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2011.12.024","article-title":"Upper tract urothelial carcinoma: current treatment and outcomes","volume":"79","author":"Ristau BT","year":"2012","unstructured":"Ristau BT, Tomaszewski JJ, Ost MC. Upper tract urothelial carcinoma: current treatment and outcomes. Urology. 2012, 79:749-56. 10.1016\/j.urology.2011.12.024","journal-title":"Urology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat AM","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, et al.. Bladder cancer. Lancet. 2016, 388:2796-2810. 10.1016\/s0140-6736(16)30512-8","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk M","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, et al.. European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol. 2022, 81:75-94. 10.1016\/j.eururo.2021.08.010","journal-title":"Eur Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2023.01.004","article-title":"Bladder recurrence following upper tract surgery for urothelial carcinoma: a contemporary review of risk factors and management strategies","volume":"49","author":"Mertens LS","year":"2023","unstructured":"Mertens LS, Sharma V, Matin SF, Boorjian SA, Houston Thompson R, van Rhijn BW, Masson-Lecomte A. Bladder recurrence following upper tract surgery for urothelial carcinoma: a contemporary review of risk factors and management strategies. Eur Urol Open Sci. 2023, 49:60-6. 10.1016\/j.euros.2023.01.004","journal-title":"Eur Urol Open Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2025.10.005","article-title":"Genotype-phenotype characterization of lynch syndrome-associated upper tract urothelial carcinoma","author":"Labbate C","year":"2025","unstructured":"Labbate C, Igel DA, Saporito D, et al.. Genotype-phenotype characterization of lynch syndrome-associated upper tract urothelial carcinoma. Eur Urol Oncol. 2025, 10.1016\/j.euo.2025.10.005","journal-title":"Eur Urol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2010.076992","article-title":"Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers","volume":"47","author":"van der Post RS","year":"2010","unstructured":"van der Post RS, Kiemeney LA, Ligtenberg MJ, et al.. Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. J Med Genet. 2010, 47:464-70. 10.1136\/jmg.2010.076992","journal-title":"J Med Genet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/461066-recurrent-multifocal-urothelial-carcinoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:04:33Z","timestamp":1772629473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/461066-recurrent-multifocal-urothelial-carcinoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.104653","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,4]]}}}